Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Obesity programs: <li /> Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide ...

EQS-News: ABIVAX / Key word (s): Miscellaneous Abivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.

MiscellaneousAbivax Publishes 2025 Financial Calendar 28.01.2025 / 08:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Publishes 2025 Financial Calendar PARIS, ...

On the Call Her Daddy podcast, American actress and stand-up comedian Amy Schumer, 43, discussed how online abuse from trolls ...

Immunic (IMUX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Faisal Khurshid from ...

After a heartbreakingly traumatic few years of health issues, Louise Thompson exclusively tells Closer what’s next as she ...

Inc. (NYSE American: PTN), a small-cap biotech company with a market capitalization of $20.4 million, has announced its corporate milestones for 2025, focusing on the development of treatments for ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) has received a consensus recommendation of “Buy” from the seven ...

Shares of ABIVAX Société Anonyme (NASDAQ:ABVX – Get Free Report) have been assigned a consensus rating of “Buy” from the ...

Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

The stoma/ostomy care market is projected to grow at a 4.9% CAGR, reaching USD 6.5 billion by 2033. The rising prevalence of ...